24 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
to approve his lawsuit as an Israeli class action lawsuit against the Company. The claim alleges that the Company did not make various documents filed
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
Israeli plaintiff filed a request in the Israeli court of Tel Aviv to approve an Israeli class action lawsuit against the Company. The claim alleges
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Feb 19
Asset Purchase Agreement
4:57pm
the following respective meanings:
“Action” means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation
424B3
ENLV
Enlivex Therapeutics Ltd
10 Jul 19
Prospectus supplement
8:18am
Israeli court at the time the lawsuit is instituted in the foreign court; and
the judgment and the obligations imposed by the judgment
F-3
ENLV
Enlivex Therapeutics Ltd
28 Jun 19
Shelf registration (foreign)
9:48am
matter between the same parties;
an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit
F-3
uole0cdigcquy5e
7 Jun 19
Shelf registration (foreign)
3:31pm
F-3
yq2kfb9 3wgv6
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-1.1
kk8i5g tipnijzxpuy
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
f72g5c 7oxrh2n3daezu
5 Mar 20
Report of Foreign Private Issuer
8:16am
F-1/A
uzvu0
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B5
w4mf43eymg
26 Feb 20
Prospectus supplement for primary offering
8:23am
424B4
bw7h77nwbo3
31 Jul 14
Prospectus supplement with pricing info
12:00am
424B5
hkat1yzpc
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
5b5m5j4f
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B5
kpe8a6b4br0 uksty9g
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-10.1
a89z nv8d1zwb
22 Oct 20
Report of Foreign Private Issuer
8:47am
20-F
92dzy
31 Mar 15
Annual report (foreign)
12:00am
424B5
gyi5l29 x2f
18 Mar 16
Prospectus supplement for primary offering
12:00am
424B5
ue5 o6pv5y
30 Dec 22
Prospectus supplement for primary offering
4:01pm